Rebalancing metal dyshomeostasis for Alzheimer's disease therapy

被引：30
|
作者：
Yang, Guan-Jun [1 ]
Liu, Hao [2 ]
Ma, Dik-Lung [2 ]
Leung, Chung-Hang [1 ]
机构：
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Macao, Peoples R China
[2] Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong 999077, Peoples R China
来源：
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2019年 / 24卷 / 08期
基金：
中国国家自然科学基金;
关键词：
Metal dyshomeostasis; Metal ions; Alzheimer's disease; Metal chelators; A beta aggregation inhibitors; Multifunctional agents; BLOOD-BRAIN-BARRIER; A-BETA AGGREGATION; AMYLOID-BETA; MITOCHONDRIAL DYSFUNCTION; SECONDARY PREVENTION; OXIDATIVE STRESS; ION HOMEOSTASIS; BINDING SITE; COPPER; TAU;
D O I：
10.1007/s00775-019-01712-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alzheimer's disease (AD) is a type of neurodegenerative malady that is associated with the accumulation of amyloid plaques. Metal ions are critical for the development and upkeep of brain activity, but metal dyshomeostasis can contribute to the development of neurodegenerative diseases, including AD. This review highlights the association between metal dyshomeostasis and AD pathology, the feasibility of rebalancing metal homeostasis as a therapeutic strategy for AD, and a survey of current drugs that action via rebalancing metal homeostasis. Finally, we discuss the challenges that should be overcome by researchers in the future to enable the practical use of metal homeostasis rebalancing agents for clinical application.
引用
收藏
页码：1159 / 1170
页数：12
相关论文
共 50 条
  • [11] Cellular Senescence and Iron Dyshomeostasis in Alzheimer's Disease
    Masaldan, Shashank
    Belaidi, Abdel Ali
    Ayton, Scott
    Bush, Ashley, I
    PHARMACEUTICALS, 2019, 12 (02)
  • [12] Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease
    LaFerla, FM
    NATURE REVIEWS NEUROSCIENCE, 2002, 3 (11) : 862 - 872
  • [13] Iron Dyshomeostasis and Ferroptosis: A New Alzheimer's Disease Hypothesis?
    Wang, Feixue
    Wang, Jiandong
    Shen, Ying
    Li, Hao
    Rausch, Wolf-Dieter
    Huang, Xiaobo
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [14] Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients
    Lampinen, Riikka
    Gorova, Veronika
    Avesani, Simone
    Liddell, Jeffrey R.
    Penttila, Elina
    Zavodna, Tana
    Krejcik, Zdenek
    Lehtola, Juha-Matti
    Saari, Toni
    Kalapudas, Juho
    Hannonen, Sanna
    Lopponen, Heikki
    Topinka, Jan
    Koivisto, Anne M.
    White, Anthony R.
    Giugno, Rosalba
    Kanninen, Katja M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [15] Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease
    Talwar, Puneet
    Kushwaha, Suman
    Gupta, Renu
    Agarwal, Rachna
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [16] Alzheimer's disease, metal ions and metal homeostatic therapy
    Zatta, Paolo
    Drago, Denise
    Bolognin, Silvia
    Sensi, Stefano L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (07) : 346 - 355
  • [17] Rebalancing calcium in Alzheimer disease
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 580 - 580
  • [18] Metal ions, Alzheimer's disease and chelation therapy
    Budimir, Ana
    ACTA PHARMACEUTICA, 2011, 61 (01) : 1 - 14
  • [19] Metal chelation as a potential therapy for Alzheimer's disease
    Cuajungco, MP
    Fagét, KY
    Huang, XD
    Tanzi, RE
    Bush, AI
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 292 - 304
  • [20] Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease
    Honarnejad, Kamran
    Jung, Christian K. E.
    Lammich, Sven
    Arzberger, Thomas
    Kretzschmar, Hans
    Herms, Jochen
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (02) : 293 - 302
12345